Atlas Trials

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT01419691 · COMPLETED

Trial details

NCT number
NCT01419691
Sponsor
University of Kansas Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic LymphomaLeukemia, Prolymphocytic
Start date
2011-09-01
Primary completion
2015-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.